[
    [
        {
            "time": "2021-12-21",
            "original_text": "医药行业周报：CXO及创新药板块短期受事件因素扰动 赛道性性价比逐渐突出",
            "features": {
                "keywords": [
                    "CXO",
                    "创新药",
                    "事件因素",
                    "赛道性性价比"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "医药行业周报：CXO及创新药板块短期受事件因素扰动 赛道性性价比逐渐突出",
                "Correlation": 7,
                "Sentiment": 6,
                "Importance": 7,
                "Impact": 6,
                "Duration": 7,
                "Entity_Density": 4,
                "Market_Scope": 9,
                "Time_Proximity": 6,
                "Headline_Structure": 7,
                "Source_Recency": 7
            }
        },
        {
            "time": "2021-12-21",
            "original_text": "恒瑞医药现2笔大宗交易 总成交金额3577.40万元",
            "features": {
                "keywords": [
                    "恒瑞医药",
                    "大宗交易",
                    "成交金额"
                ],
                "sentiment_score": 0.5,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "恒瑞医药现2笔大宗交易 总成交金额3577.40万元",
                "Correlation": 9,
                "Sentiment": 5,
                "Importance": 6,
                "Impact": 5,
                "Duration": 4,
                "Entity_Density": 8,
                "Market_Scope": 3,
                "Time_Proximity": 7,
                "Headline_Structure": 5,
                "Source_Recency": 8
            }
        },
        {
            "time": "2021-12-21",
            "original_text": "孙飘扬复出140天，“药茅”有变",
            "features": {
                "keywords": [
                    "孙飘扬",
                    "复出",
                    "药茅"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "孙飘扬复出140天，“药茅”有变",
                "Correlation": 9,
                "Sentiment": 6,
                "Importance": 8,
                "Impact": 7,
                "Duration": 7,
                "Entity_Density": 7,
                "Market_Scope": 4,
                "Time_Proximity": 6,
                "Headline_Structure": 8,
                "Source_Recency": 7
            }
        },
        {
            "time": "2021-12-21",
            "original_text": "恒瑞医药今日大宗交易成交25万股，成交价50.0元溢价0.68%",
            "features": {
                "keywords": [
                    "恒瑞医药",
                    "大宗交易",
                    "溢价"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "恒瑞医药今日大宗交易成交25万股，成交价50.0元溢价0.68%",
                "Correlation": 10,
                "Sentiment": 6,
                "Importance": 6,
                "Impact": 5,
                "Duration": 3,
                "Entity_Density": 9,
                "Market_Scope": 2,
                "Time_Proximity": 9,
                "Headline_Structure": 6,
                "Source_Recency": 9
            }
        },
        {
            "time": "2021-12-21",
            "original_text": "掘金创新药｜腾盛博药贡献首款国产新冠特效药：全球已有7款同类药物上市 市场机遇集中在海外",
            "features": {
                "keywords": [
                    "创新药",
                    "腾盛博药",
                    "新冠特效药",
                    "海外市场"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "掘金创新药｜腾盛博药贡献首款国产新冠特效药：全球已有7款同类药物上市 市场机遇集中在海外",
                "Correlation": 6,
                "Sentiment": 7,
                "Importance": 7,
                "Impact": 6,
                "Duration": 6,
                "Entity_Density": 5,
                "Market_Scope": 8,
                "Time_Proximity": 6,
                "Headline_Structure": 8,
                "Source_Recency": 7
            }
        },
        {
            "time": "2021-12-21",
            "original_text": "恒瑞医药皮下注射PD-1药物进入临床试验阶段，抗肿瘤药物竞争开始“进阶”",
            "features": {
                "keywords": [
                    "恒瑞医药",
                    "PD-1",
                    "临床试验",
                    "抗肿瘤药物"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "恒瑞医药皮下注射PD-1药物进入临床试验阶段，抗肿瘤药物竞争开始“进阶”",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 8,
                "Impact": 7,
                "Duration": 8,
                "Entity_Density": 8,
                "Market_Scope": 5,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        },
        {
            "time": "2021-12-21",
            "original_text": "超5亿元新一代抗凝药物市场，迎来新入局者",
            "features": {
                "keywords": [
                    "抗凝药物",
                    "市场",
                    "新入局者"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "超5亿元新一代抗凝药物市场，迎来新入局者",
                "Correlation": 5,
                "Sentiment": 6,
                "Importance": 6,
                "Impact": 5,
                "Duration": 6,
                "Entity_Density": 4,
                "Market_Scope": 7,
                "Time_Proximity": 6,
                "Headline_Structure": 7,
                "Source_Recency": 7
            }
        },
        {
            "time": "2021-12-21",
            "original_text": "华东医药、人福医药等多药企昨遭北向资金席位净流入",
            "features": {
                "keywords": [
                    "华东医药",
                    "人福医药",
                    "北向资金",
                    "净流入"
                ],
                "sentiment_score": 0.5,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "华东医药、人福医药等多药企昨遭北向资金席位净流入",
                "Correlation": 6,
                "Sentiment": 7,
                "Importance": 7,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 7,
                "Market_Scope": 8,
                "Time_Proximity": 8,
                "Headline_Structure": 6,
                "Source_Recency": 9
            }
        },
        {
            "time": "2021-12-21",
            "original_text": "A股融资融券日报：两融余额减少7.19亿元（12月21日）",
            "features": {
                "keywords": [
                    "A股",
                    "融资融券",
                    "两融余额",
                    "减少"
                ],
                "sentiment_score": 0.3,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "整体市场"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "A股融资融券日报：两融余额减少7.19亿元（12月21日）",
                "Correlation": 4,
                "Sentiment": 4,
                "Importance": 5,
                "Impact": 4,
                "Duration": 4,
                "Entity_Density": 2,
                "Market_Scope": 9,
                "Time_Proximity": 6,
                "Headline_Structure": 5,
                "Source_Recency": 7
            }
        }
    ]
]